SMS CO., LTD.
2175・Prime Market・Services
Business
SMS CO., LTD. sets forth its group mission as "contributing to society by improving quality of life through the construction of information infrastructure suited to an aging society." Domestically, the company operates across three areas: career support for medical/nursing care and welfare for the disabled workers (career field), a management support platform "Caipoke" for nursing care/welfare for the disabled providers (nursing care/welfare for the disabled providers field), and new businesses in the healthcare and senior life domains (business development field). Overseas, the company operates a medical platform business in APAC as well as a Global Career business. Defining platforms that connect workers, providers, and end users as information infrastructure, the company provides a range of services addressing the structural challenges facing Japanese society amid accelerating declining birthrate, aging, and population decline.
Business Model
In the career field, the company earns recruitment placement fees and revenue from qualification schools through matching medical/nursing care and disability welfare workers with employers. In the nursing care/disability welfare provider field, it improves ARPU by combining the subscription-based "Caipoke" with paid optional services such as factoring and tablets. In the business development field, it accumulates recurring revenue through BtoB services such as remote health guidance and occupational health. Overseas, it earns revenue by providing marketing support to pharmaceutical companies and others.
Company Strengths
The management support platform for long-term care/disability welfare providers, "Caipoke," has one of the industry's largest bases, with 62% of home-visit care providers connected to it. Built around an insurance claims function, it provides more than 40 services—including recruitment, procurement, finance, and M&A—on a one-stop basis. Owing to growth in the member base and expanded use of factoring and paid options, segment revenue for FY2026 (ending March 2026) reached ¥13,715 million (up 14.7% year on year), maintaining high growth.
Since its founding in 2003, the company has built cross-occupational recruitment placement services, direct recruiting, and qualification schools spanning long-term care, nursing, childcare, rehabilitation, dietitians, and other professions. Career segment revenue for FY2026 (ending March 2026) was ¥38,276 million (up 5.7% year on year), accounting for approximately 59% of total company revenue, with both Kaigo Career and Iryo Career growing amid providers' strong hiring appetite. The job-seeker and provider database accumulated over more than 20 years of track record is an asset that competitors would find difficult to replicate in a short period.
Operating cash flow for FY2026 (ending March 2026) remained at a high level of ¥8,799 million (a substantial increase from ¥5,806 million in the prior period). Under a progressive dividend policy targeting a consolidated dividend payout ratio of 30%, the company plans to increase its per-share dividend to ¥30.50 in FY2027 (ending March 2026), and during the current period it invested ¥3,999 million in share buybacks. Even after recording a net loss for the period due to overseas impairment, the stable operating cash flow generation capacity supports the continuation of shareholder returns.
ENVALITH's Perspective
Performance Trend
Revenue grew for five consecutive fiscal years, rising from ¥38,899 million in FY2022 (ended March 2022) to ¥64,735 million in FY2026 (ending March 2026), representing a CAGR of approximately 13.6%. However, the growth rate has shown a decelerating trend, falling from 18.5% in FY2024 (ended March 2024) to 12.9% in FY2025 (ended March 2025) and 6.2% in FY2026 (ending March 2026). Operating profit peaked at ¥8,269 million in FY2024 (ended March 2024), declined to ¥6,335 million in FY2025 (ended March 2025) due to increased upfront investment, and recovered to ¥6,787 million in FY2026 (ending March 2026), showing a recovery trend. However, due to the recording of an impairment loss of ¥22,957 million (goodwill ¥8,649 million, trademark rights ¥13,041 million, customer relationship assets ¥589 million, software ¥677 million) following the failure of Medical Platform (MIMS Group) to meet its performance plan, net loss attributable to owners of the parent fell to ¥14,317 million. Operating cash flow improved significantly year-on-year to ¥8,799 million, indicating that underlying earnings power has been maintained.
Growth Strategy
Rebuilding the earnings base through organic growth across four domestic business areas and a fundamental review of the overseas business
The company will actively recruit Career Partners year-round, focusing on the nursery care and long-term care/disability welfare fields, while pursuing productivity gains through AI-driven matching processes. For Direct Recruiting, upfront investment is being made to strengthen the sales structure, awareness initiatives, and expand customer success personnel. Approximately ¥2.0 billion in upfront investment is planned for FY2027 (ending March 2027).
The company is advancing the development of high-value-added products through migration to "Caipoke Connect" and the addition of AI functionality, including through capital and business alliances with external parties. Strengthening of the sales structure for "Kabenashi Cloud" is being carried out in parallel. In FY2026 (ended March 2026), the long-term care and disability welfare provider segment grew steadily, up 14.7% year on year.
Following the shortfall in the MIMS Group's performance against plan, the company is conducting a fundamental review of the business based on criteria such as future growth potential and profitability. All options, including alliances with other companies and the use of external capital, are under consideration. In FY2026 (ended March 2026), an impairment loss of ¥22,957 million was recorded, and substantially all of the related intangible fixed assets have now been amortized.
Amid the continuing impact on cross-border travel from the worsening situation in the Middle East, the company aims to achieve growth by expanding its medical business partners and strengthening its presence in other areas such as Europe, the US, and Australia. Given the growing global demand for medical personnel, the company judges that there is substantial room for long-term growth.
Following the transition to a new management structure on January 1, 2026, the company will, from FY2027 (ending March 2027), provide business explanations and performance disclosures under three segments: "Career," "Long-Term Care and Disability Welfare Management Support," and "Overseas." This is intended to improve transparency in management oversight and clarify the responsibilities of each business.
Last updated: July 19, 2026

